Europeans can now receive a device that can partially restore their vision loss. Americans may not have to wait long to get it, either. Science Corporation announced Wednesday that European regulators had approved the commercial sale of the startup’s retinal implant that improves eyesight for patients with age-related macular degeneration in their central vision, enough to read books and road signs more clearly.

“We have a cochlear implant for vision now,” said Science founder and CEO Max Hodak. This article is exclusive to STAT+ subscribers Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+. Already have an account?

Log in